
A new investigational treatment targets the root cause of a life-threatening liver condition connected to obesity and diabetes, offering hope for millions of patients. Scientists at the University of California, San Diego School of Medicine have developed an investigational drug that could provide a new treatment for metabolic dysfunction-associated steatohepatitis (MASH). This severe type of [...]